A compound called sulforaphane-nitrile, found in broccoli sprouts, does not activate protective cellular pathways in prostate cells, even at high doses, while sulforaphane does so strongly at much lower doses.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review would determine whether SFN-NIT consistently lacks bioactivity across all human cell types and molecular targets beyond prostate cells.
A systematic review and meta-analysis of all published in vitro studies testing SFN-NIT on human cell lines for Nrf2 activation, HDAC inhibition, apoptosis induction, and antioxidant response, across tissues (liver, colon, lung, breast), with standardized concentrations and assays.
An RCT could determine whether individuals with high SFN-NIT excretion have reduced biomarkers of Nrf2 activation in blood cells compared to those with low SFN-NIT excretion.
A double-blind RCT of 120 adults with high vs. low SFN-NIT excretion (pre-screened), randomized to consume 100 μmol glucoraphanin daily for 8 weeks, with primary outcome being Nrf2 target gene expression (NQO-1, HO-1) in peripheral blood mononuclear cells.
A cohort study could determine whether SFN-NIT excretion predicts reduced Nrf2 pathway activation in human tissues over time.
A 5-year prospective cohort of 500 adults with annual measurement of SFN-NIT excretion after broccoli sprout challenge and biannual assessment of Nrf2 pathway activity in buccal or nasal epithelial cells.
A case-control study could compare Nrf2 pathway activity in prostate tissue from men with high vs. low SFN-NIT excretion.
A case-control study comparing Nrf2 target gene expression and HDAC activity in prostate tissue biopsies from 50 men with high SFN-NIT excretion (>70 μmol/72h) and 50 with low excretion (<10 μmol/72h), all consuming a standardized broccoli sprout dose 24h prior to biopsy.
A cross-sectional study could confirm the association between SFN-NIT levels and Nrf2 pathway activity in human cells at a single time point.
A cross-sectional study of 100 healthy adults consuming a single 100 μmol glucoraphanin dose, with blood drawn at 24h and PBMCs isolated to measure NQO-1 and HO-1 mRNA expression and HDAC activity, correlated with plasma SFN-NIT levels.